ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000257497.1	ABT-263 (navitoclax)	Chronic Lymphocytic Leukemia	0.020151146	Resistant
ENSG00000257497.1	ABT-263 (navitoclax)	Pancreatic adenocarcinoma	0.035353023	Sensitive